During the face-to-face training, both the research team and the
medical infectologist responsible for overseeing biosafety protocols were present. Interviewer
health monitoring was performed through periodic assessments conducted before the
initiation of each survey stage, utilizing health questionnaires in conjunction
with the results of serological testing by immunochromatographic assay.